Mebion Pharmaceuticals Private Limited
About Mebion Pharmaceuticals Private Limited
Data last updated:
Mebion Pharmaceuticals Private Limited is a private limited company based in Shahdol, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2019PTC047780. Its GSTIN is 23AAMCM4441N1Z6 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gulam Dastgir and Pradeep Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C/O Ram Kishor Pandey Ward No. 07 Goukul Dham Ambedkar Nagar, Shahdol, Madhya Pradesh, India – 486110.
As per the financials filed for FY 2022, the company reported a revenue of ₹96,468, a growth of 75% compared to the previous year. For the same year it recorded a net loss of ₹5,882 (net margin -6.1%) and EBITDA of -₹5,882 (EBITDA margin -6.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Ram Kishor Pandey Ward No. 07 Goukul Dham Ambedkar Nagar, Shahdol, Madhya Pradesh, India – 486110
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mebion Pharmaceuticals Private Limited
The main business activity of Mebion Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mebion Pharmaceuticals Private Limited FY 2022 filings available
Mebion Pharmaceuticals Private Limited reported revenue of ₹96,468 (up 75% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Mebion Pharmaceuticals Private Limited
Revenue rose 75% in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mebion Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹96,468 | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹5,882 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹5,882 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Mebion Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -6.1% | •••• | •••• | •••• |
| Net Profit Margin | -6.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mebion Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gulam Dastgir | Director | 12 Feb 2019 | 7 Years 8 Months | Current |
| Pradeep Kumar Pandey | Director | 12 Feb 2019 | 7 Years 8 Months | Current |
| Veerendra Jawarkar | Director | 12 Feb 2019 | 7 Years 8 Months | Current |
Peer Comparison of Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediking Pharmaceuticals Private Limited | ₹97,100 (FY 2023) | •••• | •••• | •••• | Allahabad, Uttar Pradesh, India | |
| Granite Pharmaceuticals Private Limited | ₹96,921 (FY 2025) | •••• | •••• | -71.0% | •••• | Patna, Bihar, India |
| Goill Pharmaceuticals Private Limited | ₹96,698 (FY 2023) | •••• | •••• | •••• | Patna, Bihar, India | |
| Bluegreen Pharmaceuticals Private Limited | ₹96,592 (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Nabh Pharmaceuticals Private Limited | ₹96,588 (FY 2025) | •••• | •••• | 304.0% | •••• | New Delhi, Delhi, India |
| Mebion Pharmaceuticals Private Limited this company | ₹96,468 (FY 2022) | •••• | •••• | 75.0% | •••• | Shahdol, Madhya Pradesh, India |
| Medglobe Pharmaceuticals Private Limited | ₹96,163 (FY 2024) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Optimize Pharmaceuticals Private Limited | ₹95,170 (FY 2021) | •••• | •••• | •••• | Samastipur, Bihar, India | |
| Biopytix Pharmaceuticals Private Limited | ₹94,929 (FY 2025) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Gupixi Pharmaceuticals Private Limited | ₹94,790 (FY 2025) | •••• | •••• | -21.0% | •••• | Meerut, Uttar Pradesh, India |
| Lorda Pharmaceuticals Private Limited | ₹94,569 (FY 2016) | •••• | •••• | -33.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Mebion Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Mebion Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mebion Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Mebion Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Gulam Dastgir was appointed as Director on 12 Feb 2019.
Credit Ratings, Litigation & Regulatory Alerts for Mebion Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mebion Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mebion Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAMCM4441N1Z6 | Madhya Pradesh | Active | 07 Nov 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mebion Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mebion Pharmaceuticals Private Limited
Mebion Pharmaceuticals is an active private limited company based in Shahdol, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 February 2019 (7+ years old) and is registered under CIN U24230MP2019PTC047780.
Mebion Pharmaceuticals reported revenue of ₹96,468 for FY 2022 (up 75% YoY).
Mebion Pharmaceuticals has 3 current directors:
- Gulam Dastgir - Director
- Pradeep Kumar Pandey - Director
- Veerendra Jawarkar - Director
Mebion Pharmaceuticals reported a net loss of ₹5,882 (net margin -6.1%) and EBITDA of -₹5,882 (EBITDA margin -6.1%) for FY 2022, as per its filed financial statements.
The GSTIN of Mebion Pharmaceuticals is 23AAMCM4441N1Z6, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Mebion Pharmaceuticals is U24230MP2019PTC047780. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mebion Pharmaceuticals was incorporated on 12 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Mebion Pharmaceuticals by revenue are Mediking Pharmaceuticals Private Limited, Granite Pharmaceuticals Private Limited, Goill Pharmaceuticals Private Limited, Bluegreen Pharmaceuticals Private Limited, Nabh Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Gulam Dastgir was appointed as Director on 12 Feb 2019. Pradeep Kumar Pandey was appointed as Director on 12 Feb 2019. Veerendra Jawarkar was appointed as Director on 12 Feb 2019.
The registered office of Mebion Pharmaceuticals is at CO Ram Kishor Pandey Ward No. 07 Goukul Dham Ambedkar Nagar, Shahdol, Madhya Pradesh, India – 486110.
Mebion Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.